TY - JOUR
TI - Pembrolizumab for metastatic melanoma
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2015
ET - 2015/08/10
VL - 38
IS - 5
SP - 180
EP - 182
DO - 10.18773/austprescr.2015.066
LA - eng
UR - https://australianprescriber.tg.org.au/articles/pembrolizumab-for-metastatic-melanoma.html
KW - Keytruda
KW - pembrolizumab
KW - metastatic malignant melanoma
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -